GE HealthCare director Kevin Lobo files Form 3

GE HealthCare Technologies Inc. director Kevin Lobo filed an initial Form 3, which is a required statement of beneficial ownership for company insiders.

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. director Kevin Lobo filed an initial Form 3, which is a required statement of beneficial ownership for company insiders. This filing establishes his reporting status as a director but does not report any insider stock transactions or positions in this excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Kevin Lobo's Form 3 filing for GEHC indicate?

The Form 3 filing shows that Kevin Lobo is now a reporting insider of GE HealthCare Technologies Inc. (GEHC) as a director. It is an initial ownership statement and, in this excerpt, does not list any stock transactions or holdings.

Were any GEHC shares bought or sold in Kevin Lobo's Form 3?

No, this Form 3 excerpt shows no reported transactions in GEHC shares by Kevin Lobo. All transaction counters, including buy, sell, acquire, dispose, and derivative activity, are recorded as zero in the transaction summary data provided.

Does Kevin Lobo’s GEHC Form 3 include derivative securities information?

No, the Form 3 data provided shows an empty derivative summary for Kevin Lobo. This means there are no listed options, warrants, or other derivative positions associated with him in this particular initial ownership statement excerpt.

What is the role of Kevin Lobo at GE HealthCare Technologies Inc.?

The filing identifies Kevin Lobo as a director of GE HealthCare Technologies Inc. He is not reported as an officer or a ten percent owner in this Form 3, which focuses on his status as a board member subject to insider reporting rules.

Does the GEHC Form 3 for Kevin Lobo show any net buying or selling activity?

No, the transaction summary shows netBuySellShares of 0 and a netBuySellDirection of neutral. This confirms that the excerpted Form 3 does not reflect any net buying or selling of GEHC securities by Kevin Lobo at this time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 04:06 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lobo Kevin

(Last) (First) (Middle)

500 WEST MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/13/2026

3. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24.1 - Power of Attorney

No securities are beneficially owned.

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.